We are live on ! Find out more
CIC

Crawford Investment Counsel Portfolio holdings

AUM $5.85B
1-Year Est. Return 12.61%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+12.61%
3 Year Est. Return
+44.31%
5 Year Est. Return
+59.61%
10 Year Est. Return
+1,024.8%
AUM
$3.22B
AUM Growth
+$140M
Cap. Flow
+$7.21M
Cap. Flow %
0.22%
Top 10 Hldgs %
26.27%
Holding
261
New
18
Increased
96
Reduced
95
Closed
9

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$9.13M
2
PSMT icon
Pricesmart
PSMT
+$7.64M
3
JCI icon
Johnson Controls International
JCI
+$6.21M
4
CVS icon
CVS Health
CVS
+$5.26M
5
MSFT icon
Microsoft
MSFT
+$4.19M

Sector Composition

Rank Sector Weight
1 Financials 22.06%
2 Technology 17.83%
3 Healthcare 13.08%
4 Industrials 11.82%
5 Consumer Staples 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN.PRA
151
DELISTED
Allergan plc
AGN.PRA
$1.25M 0.04%
2,132
+560
+36% +$361K
AMGN icon
152
Amgen
AMGN
$226B
$1.22M 0.04%
7,001
+146
+2% +$25.8K
INTC icon
153
Intel
INTC
$492B
$1.21M 0.04%
26,149
-1,800
-6% -$78.5K
TGT icon
154
Target
TGT
$69B
$1.2M 0.04%
18,440
-1,399
-7% -$84.5K
NSC icon
155
Norfolk Southern
NSC
$75B
$1.19M 0.04%
8,181
-410
-5% -$55.1K
SLB icon
156
SLB Ltd
SLB
$78.9B
$1.14M 0.04%
16,979
+295
+2% +$19.1K
ADC icon
157
Agree Realty
ADC
$9.22B
$1.14M 0.04%
22,072
-5,610
-20% -$278K
NEE icon
158
NextEra Energy
NEE
$177B
$1.13M 0.04%
29,036
+1,272
+5% +$49.1K
MSM icon
159
MSC Industrial Direct
MSM
$6.87B
$1.12M 0.03%
+11,630
New +$972K
PDCO
160
DELISTED
Patterson Companies, Inc.
PDCO
$1.12M 0.03%
+31,122
New +$1.14M
PEP icon
161
PepsiCo
PEP
$188B
$1.11M 0.03%
9,256
-144
-2% -$16.4K
BMY icon
162
Bristol-Myers Squibb
BMY
$132B
$1.08M 0.03%
17,694
-2,300
-12% -$144K
GNTX icon
163
Gentex
GNTX
$5.02B
$1.06M 0.03%
50,840
-5,220
-9% -$104K
COST icon
164
Costco
COST
$423B
$1.05M 0.03%
5,671
-30
-0.5% -$5.18K
CORE
165
DELISTED
Core Mark Holding Co., Inc.
CORE
$1.05M 0.03%
+33,342
New +$1.07M
LLY icon
166
Eli Lilly
LLY
$1.1T
$1.04M 0.03%
12,275
-585
-5% -$49.8K
TMO icon
167
Thermo Fisher Scientific
TMO
$222B
$1.01M 0.03%
5,302
UVV icon
168
Universal Corp
UVV
$1.18B
$1M 0.03%
19,039
+2,000
+12% +$111K
MSA icon
169
Mine Safety
MSA
$7.45B
$985K 0.03%
+12,700
New +$1.01M
GD icon
170
General Dynamics
GD
$107B
$972K 0.03%
4,776
DOC
171
DELISTED
PHYSICIANS REALTY TRUST
DOC
$955K 0.03%
+53,084
New +$952K
ADP icon
172
Automatic Data Processing
ADP
$109B
$941K 0.03%
8,031
MCHP icon
173
Microchip Technology
MCHP
$44.2B
$928K 0.03%
21,114
TSS
174
DELISTED
Total System Services, Inc.
TSS
$898K 0.03%
11,351
-640
-5% -$46.5K
EPD icon
175
Enterprise Products Partners
EPD
$82.2B
$873K 0.03%
32,914
-4,438
-12% -$112K

Similar funds

Crawford Investment Counsel's Q4 2017 Portfolio in Review

As of Q4 2017, Crawford Investment Counsel held 261 positions worth $3.22B, up 4.5% from $3.08B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Crawford Investment Counsel's Q4 2017 filing shows 18 new, 96 increased, 95 reduced and 9 closed positions. Its largest new stake was Glacier Bancorp: 52,847 shares worth $2.08M. The largest sale was Cardinal Health, an estimated $9.13M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

  • Crawford Investment Counsel's largest Q4 2017 buy was Glacier Bancorp: 52,847 shares worth $2.08M.
  • Crawford Investment Counsel added most to Cullen/Frost Bankers in Q4 2017, an estimated $12.5M increase.
  • Crawford Investment Counsel's biggest Q4 2017 reduction was Cardinal Health, cutting an estimated $9.13M.
  • Crawford Investment Counsel fully exited Brighthouse Financial in Q4 2017, selling an estimated $4.17M.
  • Crawford Investment Counsel's ten largest holdings make up 26% of its $3.22B portfolio in Q4 2017.
  • Crawford Investment Counsel opened 18 new positions and closed 9 in Q4 2017.
  • Crawford Investment Counsel's portfolio value rose 4.5% quarter-over-quarter to $3.22B.

Based on Crawford Investment Counsel's 13F filing for Q4 2017, filed 13 Feb 2018.